Elevated DHEA-S: Diagnostic Approach
An elevated DHEA-S level requires immediate evaluation to exclude adrenal tumors when levels exceed 600 µg/dL (16,000 nmol/L), followed by systematic assessment for PCOS, non-classic congenital adrenal hyperplasia, and Cushing's disease based on the degree of elevation and clinical context. 1
Critical Threshold for Urgent Evaluation
DHEA-S >600 µg/dL (16,000 nmol/L) indicates possible androgen-secreting adrenal cortical adenoma and requires urgent abdominal imaging (CT or MRI). 1 This threshold represents a medical emergency as these tumors are often associated with hypercorticism and require rapid surgical intervention.
Most Common Causes by Clinical Context
In Women of Reproductive Age (20-29 years)
The most frequent cause is polycystic ovary syndrome (PCOS), particularly non-classic phenotypes (B and C). Elevated DHEA-S occurs in approximately 33% of young PCOS patients and is associated with:
- Higher testosterone and androstenedione levels 2
- Increased prevalence in non-classic PCOS phenotypes (B or C) compared to classic phenotype A 2
- Presence of acne (independent of testosterone levels) 3
- Paradoxically reduced risk of abdominal obesity 3
Important caveat: DHEA-S levels decline by 40% from the twenties to thirties, so age-appropriate reference ranges are critical 2. A "high" DHEA-S in a 40-year-old may be normal for a 25-year-old.
In Anovulatory Women
50% of euprolactinemic anovulatory women have elevated DHEA-S, and notably, 77% of these women are non-hirsute 4. This challenges the assumption that elevated adrenal androgens always present with obvious clinical hyperandrogenism.
Systematic Diagnostic Algorithm
Step 1: Confirm Elevation and Assess Severity
- Repeat DHEA-S measurement to confirm
- Check testosterone and androstenedione levels (typically elevated together) 2
- If DHEA-S >600 µg/dL → proceed immediately to imaging 1
Step 2: Rule Out Adrenal Pathology
For moderately elevated DHEA-S (<600 µg/dL):
- Perform 1-mg overnight dexamethasone suppression test to evaluate for Cushing's disease 5
- Cushing's disease with macronodular adrenal hyperplasia can present with markedly elevated DHEA-S (>10,000 ng/mL) 6
- Check morning cortisol and ACTH levels
Step 3: Evaluate for PCOS
Look for:
- Irregular menstrual cycles
- Clinical hyperandrogenism (hirsutism, acne, androgenic alopecia)
- Measure 17-hydroxyprogesterone (17-OHP) to screen for non-classic 21-hydroxylase deficiency 1
- Consider ACTH stimulation test if 17-OHP is borderline elevated
Key finding: In PCOS patients with elevated DHEA-S, approximately 34% show exaggerated DHEA-S response to ACTH stimulation, suggesting mild 3β-hydroxysteroid dehydrogenase deficiency 4
Step 4: Assess Metabolic Context
- Measure SHBG (typically reduced in metabolic syndrome, obesity, insulin resistance) 1
- Calculate free testosterone using total testosterone and SHBG
- Evaluate for insulin resistance with fasting glucose and insulin
- Check lipid profile
Clinical pearl: Unlike testosterone, elevated DHEA-S in PCOS is inversely correlated with waist circumference, BMI, insulin resistance, and triglycerides 3. This suggests DHEA-S elevation may represent a distinct metabolic subtype.
Rare but Important Causes
Medication and Systemic Conditions
- Thyroid hormone therapy or analogues can alter SHBG and androgen interpretation 1
- Antiepileptic drugs (e.g., valproate) increase SHBG 1
- Hyperthyroidism or liver disease (particularly cirrhosis) can elevate SHBG and affect total testosterone interpretation 1
Genetic Enzyme/Transporter Defects
Very rare cases involve:
- Steroid sulfatase (STS) mutations 7
- Breast cancer resistance protein (BCRP) variants affecting DHEA-S efflux 7
- These should only be considered after excluding all common causes
Common Pitfalls to Avoid
Ignoring age-specific reference ranges: DHEA-S declines dramatically with age; use age-matched controls 2
Assuming normal testosterone excludes hyperandrogenism: Isolated DHEA-S elevation occurs, particularly with reduced SHBG 1
Missing non-hirsute hyperandrogenism: 77% of anovulatory women with elevated DHEA-S lack hirsutism 4
Failing to check timing in menstruating women: Verify cycle phase and avoid assaying during thyroid hormone or estrogenic medication use 1
Not pursuing imaging for very high levels: Any DHEA-S >600 µg/dL requires imaging regardless of other findings 1
Clinical Significance Beyond Diagnosis
Elevated DHEA-S in PCOS predicts:
- Higher overall androgen production 2
- Increased acne risk (OR 2.15 for DHEA-S >6.68 µmol/L) 3
- Lower risk of abdominal obesity and metabolic complications 3
This suggests DHEA-S elevation may identify a PCOS subtype with different metabolic trajectory despite higher androgen burden.